Artificial intelligence-assisted detection and optical differentiation of colorectal lesions in Lynch syndrome surveillance (CADLY2): a multicentre, open-label, randomised controlled superiority trial

IF 39.1 1区医学 Q1 GASTROENTEROLOGY & HEPATOLOGY

Lancet Gastroenterology & Hepatology Pub Date : 2026-07-16 DOI:10.1016/s2468-1253(26)00163-9

Robert Hüneburg, Querijn N E van Bokhorst, Maria Pellisé, Francesc Balaguer, Angelo Brunori, Thomas Rösch, Deepak B Vangala, Kien Vu Trung, Arne Kandulski, Britt B S L Houwen, Hanneke Beaumont, Dewkoemar Ramsoekh, Christian P Strassburg, Raf Bisschops, Alexander Link, Tim Marwitz, Jonas Rogee, Katrin van Beekum, Christoph Engel, Evelien Dekker, Jacob Nattermann, Anne-Sophie Layritz, Kristin Gehrmann, Sonja Haas, Rebecca Sturm, Antonia Schuler, Ronny Dathe, Maria Daca Alvarez, Oswaldo Ortiz, Liseth Rivero, Teresa Ocaña, Hardeep Kumari, Joaquin Andres Castillo, Manon van der Vlugt, Joep Grootjans, Barbara A.J. Bastiaansen, Dominik Heling, Dominik J Kaczmarek, Michael Pohl, Michael Steckstor, Josef Pospiech

引用次数: 0

查看原文本刊更多论文

Lynch综合征监测（CADLY2）中结直肠病变的人工智能辅助检测和光学鉴别：一项多中心、开放标签、随机对照的优势试验

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Lancet Gastroenterology & Hepatology Medicine-Hepatology

CiteScore

50.30

自引率

1.10%

发文量

期刊介绍： The Lancet Gastroenterology & Hepatology is an authoritative forum for key opinion leaders across medicine, government, and health systems to influence clinical practice, explore global policy, and inform constructive, positive change worldwide. The Lancet Gastroenterology & Hepatology publishes papers that reflect the rich variety of ongoing clinical research in these fields, especially in the areas of inflammatory bowel diseases, NAFLD and NASH, functional gastrointestinal disorders, digestive cancers, and viral hepatitis.